Cargando…
Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation
Here we explored the role of interleukin-1β (IL-1β) repressor cytokine, IL-1 receptor antagonist (IL-1rn), in both healthy and abnormal hematopoiesis. Low IL-1RN is frequent in acute myeloid leukemia (AML) patients and represents a prognostic marker of reduced survival. Treatments with IL-1RN and th...
Autores principales: | Villatoro, Alicia, Cuminetti, Vincent, Bernal, Aurora, Torroja, Carlos, Cossío, Itziar, Benguría, Alberto, Ferré, Marc, Konieczny, Joanna, Vázquez, Enrique, Rubio, Andrea, Utnes, Peter, Tello, Almudena, You, Xiaona, Fenton, Christopher G., Paulssen, Ruth H., Zhang, Jing, Sánchez-Cabo, Fátima, Dopazo, Ana, Vik, Anders, Anderssen, Endre, Hidalgo, Andrés, Arranz, Lorena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810723/ https://www.ncbi.nlm.nih.gov/pubmed/36596811 http://dx.doi.org/10.1038/s41467-022-35700-9 |
Ejemplares similares
-
Author Correction: Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation
por: Villatoro, Alicia, et al.
Publicado: (2023) -
Leukemia Stem Cell Release From the Stem Cell Niche to Treat Acute Myeloid Leukemia
por: Villatoro, Alicia, et al.
Publicado: (2020) -
Identifying predictive signalling networks for Vedolizumab response in ulcerative colitis
por: Singh, Amrinder, et al.
Publicado: (2022) -
Identifying anti-TNF response biomarkers in ulcerative colitis using a diffusion-based signalling model
por: Singh, Amrinder, et al.
Publicado: (2021) -
Infantile Myelofibrosis and Myeloproliferation with CDC42
Dysfunction
por: Verboon, Jeffrey M., et al.
Publicado: (2020)